Brainomix is a medtech company that develops AI imaging technology for diagnosing and treating stroke and lung fibrosis.

Refoxy Pharmaceuticals is a biotech company developing small molecule activators of the FOXO3 transcription factor to treat age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.

Aignostics is a Berlin-based AI company that transforms multi-modal pathology data into insights for biopharmaceutical clients.

Glox Therapeutics develops precision antibiotics targeting drug-resistant bacteria, with a focus on creating high-potency bacteriocins to selectively target and kill antibiotic-resistant Gram-negative pathogens while preserving the patient's microbiome.

Actym Therapeutics develops a new drug modality using genetically modified bacteria to initiate a selective immune response within the tumor microenvironment for treating solid tumors.

Otto is developing an AI-driven travel assistant tailored for small businesses and startups, offering personalized travel planning and booking services.